UTICA, N.Y., Sept 21, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- CONMED Corporation (Nasdaq: CNMD), a medical technology organization specializing in a wide range of medical devices for surgical and patient monitoring markets, announced today that the Company will make a presentation to investors at the UBS Life Sciences Conference on Monday, September 26, 2005 at 3:30 PM Eastern time. The event will be held in New York City at the Grand Hyatt Hotel.

Mr. Joseph J. Corasanti, President and Chief Operating Officer of CONMED, will discuss the Company's business. The live webcast of CONMED's presentation will be available at http://www.conmed.com in the Investor Relations - Events Calendar section of the website and will be available for replay through October 4, 2005.

CONMED Profile

CONMED is a medical technology company with an emphasis on surgical devices and equipment for minimally invasive procedures and patient monitoring. The Company's products serve the clinical areas of sports medicine-arthroscopy, powered surgical instruments, electrosurgery, cardiac monitoring disposables, endosurgery and endoscopic technologies. Surgeons and physicians in a variety of specialties including orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology use the Company's medical devices. Headquartered in Utica, New York, the Company's 2,900 employees distribute its products worldwide from eleven manufacturing locations.

SOURCE CONMED Corporation

Robert Shallish, Chief Financial Officer of CONMED Corporation, +1-315-624-3206; or
Investors - Julie Huang or Theresa Kelleher, or Media - Sean Leous, all of Financial
Dynamics, +1-212-850-5600, for CONMED

http://www.prnewswire.com